Variant report

Variant	rs73926534
Chromosome Location	chr2:46845580-46845581
allele	C/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1)
CpG islands
(count:0)
Chromatin interactive
region (count:6)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	POLR2A	chr2:46845288-46845582	K562	blood:	n/a	n/a

No data

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:46845368..46847323-chr2:47016580..47018230,2	K562	blood:
2	chr2:46768098..46772914-chr2:46841294..46848059,11	K562	blood:
3	chr2:46844525..46846523-chr2:46850500..46852298,2	MCF-7	breast:
4	chr2:46768338..46773881-chr2:46842376..46848059,6	K562	blood:
5	chr2:46788951..46790463-chr2:46844313..46846805,2	K562	blood:
6	chr2:46811229..46813597-chr2:46844623..46846343,2	K562	blood:

No data

Variant related genes	Relation type
PIGF	TF binding region
ENSG00000119729	Chromatin interaction
ENSG00000250565	Chromatin interaction

Extended variants
information (count: 24 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:15)

rs_ID	r²[population]
rs56127212	1.00[AFR][1000 genomes]
rs60085835	0.83[AFR][1000 genomes]
rs60088761	0.83[AFR][1000 genomes]
rs73926516	1.00[AFR][1000 genomes]
rs73926519	1.00[AFR][1000 genomes]
rs73926524	1.00[AFR][1000 genomes]
rs73926525	0.83[AFR][1000 genomes]
rs73926526	1.00[AFR][1000 genomes]
rs73926527	0.83[AFR][1000 genomes]
rs73926530	0.83[AFR][1000 genomes]
rs73926531	0.83[AFR][1000 genomes]
rs73926532	0.83[AFR][1000 genomes]
rs73926533	0.83[AFR][1000 genomes]
rs73926535	0.83[AFR][1000 genomes]
rs73926536	0.83[AFR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:9 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	esv2757795	chr2:46532812-46874151	Weak transcription Enhancers Active TSS Flanking Active TSS Strong transcription Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	52 gene(s)	inside rSNPs	diseases
2	esv2759046	chr2:46532812-46874151	Active TSS Enhancers Flanking Active TSS Strong transcription Weak transcription Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	52 gene(s)	inside rSNPs	diseases
3	nsv1014425	chr2:46670179-47033417	Enhancers Strong transcription Flanking Active TSS Weak transcription Active TSS Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	31 gene(s)	inside rSNPs	diseases
4	nsv535678	chr2:46670179-47033417	Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers ZNF genes & repeats Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	31 gene(s)	inside rSNPs	diseases
5	nsv873996	chr2:46670941-47065227	Strong transcription Enhancers Weak transcription Active TSS ZNF genes & repeats Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	35 gene(s)	inside rSNPs	diseases
6	nsv1009735	chr2:46724523-46913152	Weak transcription Active TSS Flanking Active TSS Enhancers Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	23 gene(s)	inside rSNPs	diseases
7	nsv533112	chr2:46800828-46959977	Enhancers Weak transcription Active TSS Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	16 gene(s)	inside rSNPs	diseases
8	nsv817517	chr2:46819371-47715140	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Flanking Active TSS Strong transcription Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	152 gene(s)	inside rSNPs	diseases
9	nsv873997	chr2:46821640-46984627	Flanking Active TSS Enhancers Weak transcription Active TSS Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	16 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:125 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:46842600-46845600	Active TSS	Aorta	Aorta
2	chr2:46843000-46845600	Active TSS	H1 Cell Line	embryonic stem cell
3	chr2:46843000-46845600	Active TSS	HUES64 Cell Line	embryonic stem cell
4	chr2:46844400-46845600	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
5	chr2:46844400-46845800	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
6	chr2:46844600-46845600	Flanking Active TSS	HMEC	breast
7	chr2:46844600-46845800	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
8	chr2:46844600-46845800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
9	chr2:46844600-46845800	Flanking Active TSS	Dnd41	blood
10	chr2:46844600-46847200	Weak transcription	Spleen	Spleen
11	chr2:46844800-46845600	Flanking Active TSS	Primary hematopoietic stem cells	blood
12	chr2:46844800-46845600	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
13	chr2:46844800-46845600	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
14	chr2:46844800-46845600	Flanking Active TSS	Brain Angular Gyrus	brain
15	chr2:46844800-46845600	Flanking Active TSS	Fetal Brain Female	brain
16	chr2:46844800-46845800	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
17	chr2:46844800-46845800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
18	chr2:46844800-46845800	Flanking Active TSS	Brain Anterior Caudate	brain
19	chr2:46844800-46845800	Flanking Active TSS	Brain Cingulate Gyrus	brain
20	chr2:46844800-46845800	Flanking Active TSS	Brain Germinal Matrix	brain
21	chr2:46844800-46845800	Flanking Active TSS	Brain Hippocampus Middle	brain
22	chr2:46844800-46845800	Flanking Active TSS	A549	lung
23	chr2:46844800-46846000	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
24	chr2:46844800-46847200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
25	chr2:46844800-46847200	Weak transcription	Lung	lung
26	chr2:46844800-46865600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
27	chr2:46844800-46868400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
28	chr2:46844800-46868400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr2:46844800-46868800	Weak transcription	Esophagus	oesophagus
30	chr2:46844800-46872200	Weak transcription	Pancreas	Pancrea
31	chr2:46845000-46845600	Enhancers	Primary monocytes fromperipheralblood	blood
32	chr2:46845000-46845600	Enhancers	Primary B cells from peripheral blood	blood
33	chr2:46845000-46845600	Flanking Active TSS	Muscle Satellite Cultured Cells	--
34	chr2:46845000-46845600	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
35	chr2:46845000-46845600	Flanking Active TSS	Pancreatic Islets	Pancreatic Islet
36	chr2:46845000-46845800	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
37	chr2:46845000-46845800	Flanking Active TSS	NHDF-Ad	bronchial
38	chr2:46845000-46845800	Flanking Active TSS	NHLF	lung
39	chr2:46845000-46846000	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
40	chr2:46845000-46846000	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
41	chr2:46845000-46846400	Weak transcription	Placenta	Placenta
42	chr2:46845000-46847000	Weak transcription	Left Ventricle	heart
43	chr2:46845200-46845600	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
44	chr2:46845200-46845600	Flanking Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
45	chr2:46845200-46845600	Enhancers	Primary neutrophils fromperipheralblood	blood
46	chr2:46845200-46845600	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
47	chr2:46845200-46845600	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
48	chr2:46845200-46845600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
49	chr2:46845200-46845600	Enhancers	Fetal Heart	heart
50	chr2:46845200-46845600	Enhancers	NHEK	skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links